Evidence map›Paper›PMID 26279023›Full record

ArticleInternational journal of radiation oncology, biology, physics2015

Pulmonary Function After Treatment for Embryonal Brain Tumors on SJMB03 That Included Craniospinal Irradiation.

Daniel M Green, Thomas E Merchant, Catherine A Billups, Dennis C Stokes, Alberto Broniscer, Ute Bartels, Murali Chintagumpala, Timothy E Hassall, Sridharan Gururangan, Geoffrey B McCowage and 6 more

Open access · greenAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Daniel M GreenDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: daniel.green@stjude.org.
Thomas E MerchantDepartment of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Catherine A BillupsDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Dennis C StokesDepartment of Pediatrics, University of Tennessee School of Medicine, Memphis, Tennessee.
Alberto BroniscerDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Ute BartelsDepartment of Haematology and Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Murali ChintagumpalaDepartment of Pediatric Medicine, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas.
Timothy E HassallDepartment of Haematology and Oncology, Royal Children's Hospital, Brisbane, Australia.
Sridharan GururanganDepartment of Pediatrics, Duke University Medical Center, Durham, North Carolina.
Geoffrey B McCowageDepartment of Pediatrics, Children's Hospital at Westmead, Sydney, Australia.
John A HeathChildren's Cancer Center, Royal Children's Hospital Melbourne, Melbourne, Australia.
Richard J CohnDepartment of Clinical Oncology, Sydney Children's Hospital, Sydney, Australia.
Michael J FisherDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Ashok SrinivasanDepartment of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Giles W RobinsonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Amar GajjarDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
St. Jude Children's Research Hospital · USRoyal Children's Hospital · AUBaylor College of Medicine · USBoston Children's Hospital · USChildren's Hospital at Westmead · AUChildren's Hospital of Philadelphia · USDuke Medical Center · USHospital for Sick Children · CAUniversity of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS CA 21765NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

purposeThe treatment of children with embryonal brain tumors (EBT) includes craniospinal irradiation (CSI). There are limited data regarding the effect of CSI on pulmonary function.

methodsProtocol SJMB03 enrolled patients 3 to 21 years of age with EBT. Pulmonary function tests (PFTs) (forced expiratory volume in 1 second [FEV1] and forced vital capacity [FVC] by spirometry, total lung capacity [TLC] by nitrogen washout or plethysmography, and diffusing capacity of the lung for carbon monoxide corrected for hemoglobin [DLCO(corr)]) were obtained. Differences between PFTs obtained immediately after the completion of CSI and 24 or 60 months after the completion of treatment (ACT) were compared using exact Wilcoxon signed-rank tests and repeated-measures models.

resultsBetween June 24, 2003, and March 1, 2010, 303 eligible patients (spine dose: ≤ 2345 cGy, 201; >2345 cGy, 102; proton beam, 20) were enrolled, 260 of whom had at least 1 PFT. The median age at diagnosis was 8.9 years (range, 3.1-20.4 years). The median thoracic spinal radiation dose was 23.4 Gy (interquartile range [IQR], 23.4-36.0 Gy). The median cyclophosphamide dose was 16.0 g/m(2) (IQR, 15.7-16.0 g/m(2)). At 24 and 60 months ACT, DLCO(corr) was <75% predicted in 23% (27/118) and 25% (21/84) of patients, FEV1 was <80% predicted in 20% (34/170) and 29% (32/109) of patients, FVC was <80% predicted in 27% (46/172) and 28% (30/108) of patients, and TLC was <75% predicted in 9% (13/138) and 11% (10/92) of patients. DLCO(corr) was significantly decreased 24 months ACT (median difference [MD] in % predicted, 3.00%; P = .028) and 60 months ACT (MD in % predicted, 6.00%; P = .033) compared with the end of radiation therapy. These significant decreases in DLCO(corr) were also observed in repeated-measures models (P = .011 and P = .032 at 24 and 60 months ACT, respectively).

conclusionsA significant minority of EBT survivors experience PFT deficits after CSI. Continued monitoring of this cohort is planned.

Indexed as

Craniospinal IrradiationAdolescentAntineoplastic Agents, AlkylatingBrain NeoplasmsChildChild, PreschoolCyclophosphamideHumansLungNeoplasms, Germ Cell and EmbryonalRespiratory Function TestsYoung AdultAntineoplastic Agents, AlkylatingCyclophosphamide

Identifiers

PMID26279023
PMCPMC4629817
OpenAlexW1806821701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.